Abstract
The four most frequently used groups of drugs in psychiatric therapy are: neuroleptics, antidepressants, anxiolytics, and lithium salts. Their introduction came largely during the past 3 decades. This review summarizes the history of the research that led to their discovery and to the present concept of their modes of action.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Axelrod JC, Whitby LG, Hertting (1961) Effect of psychotropic drugs on the uptake of 3H-norepinephrine by tissues. Science 133:383–384
Baastrup FC, Poulsen JC, Schou M, Thomsen K, Amdisen A (1970) Prophylactic lithium: doubleblind discontinuation in manic-depressive and recurrent depressive disorders. Lancet II:326–330
Berger FM (1954) The pharmacological properties of 2-methyl, 2-n propyl-1,3 propandiol dicarbamate (Miltown), a new interneural blocking agent. J Pharmacol Exp Ther 112:413–423
Brodie BB, Pletscher AP, Shore PA (1955) Evidence that serotonin has a role in brain function. Science 222:968
Cade JEJ (1949) Lithium salts in the treatment of psychic excitement. Med J Aust 36:349–352
Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methyl tyramine and nor-metanephrine in mouse brain. Acta Pharmacol 20:140–144
Carlsson A, Lindqvist M, Magnusson T (1957) 3,4-dihydroxy phenylalanine and 5-hydroxy tryptophan as reserpine antagonists. Nature 180:1200
Chessin M, Kramer ER, Scott CC (1957) Modification of the pharmacology of reserpine and serotonin by iproniazid. J Pharmacol Exp Ther 119:453–460
Courvoisier S, Fournier J, Ducrot R, Kolsky M, Koetschet P (1953) Propriétés pharmacodynamiques du chlorhydrate de chloro 3-(dimethyl amino-3′propyl)10 phenothiazine. Arch Int Pharmacodyn 92:305–360
Decourt P (1956) Mécanisme d'action de la therapeutique neurobiologene en general, et de chlorpromazine en particular en psychiatrique. Encephale 45:932–944
Delay J, Deneker P, Harl JM (1952) Utilisation en therapeutique psychiatrique d'une derivee d'hibernotherapie. Ann Med Psychol 110:112–117
Delay J, Laine B, Buisson JF (1952) Note concernant l'action de l'isoamino hydrazide dans le traitement des etats depressifs. Ann Med Psychol 110:689–692
Euler US von (1946) A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relation to adrenaline and noradrenaline. Acta Physiol Scand 12:73–97
Gay LN, Carliner PL (1949) The prevention and treatment of motion sickness. I. Seasickness. Science 109:359
Glowinski J, Axelrod J (1964) Inhibition of uptake of tritiated noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204:1318–1319
Gupta JC, Deb A, Kohali BS (1943) Preliminary observations on the use of Rauwolfia serpentine Benth in the treatment of mental disorders. Indian Med Gaz 78:547–549
Hamon J, Paraire J, Velluz J (1952) Remarques sur l'action de 4560 RP sur l'agitation maniaque. Ann Med Psychol 110:332–335
Hanlon LW, Romain M, Gilray FJ, Deitrick JE (1949) Lithium chloride as a substitute for sodium chloride in the diet. JAMA 139:688–692
Henschule WP (1961) Chlordiazepoxide for calming zoo-animals. J Am Vet Med Assoc 139:996–998
Holzbauer M, Vogt M (1956) Depression by reserpine of the noradrenergic concentration in the hypothalamus of the cat. J Neurochem 1:8–11
Janssen PAJ (1965) The evolution of the butyrophenones haloperidol and triperidol from meperidine-like 4-phenylpiperidines. Int Rev Neurobiol 8:221–263
Johnson FN, Amdisen A (1983) The first era of lithium in medicine: A historical note. Pharmacopsychiatry 16:61–63
Kline N (1955) The use of rauwolfia serpentina Benth in neuropsychiatric conditions. Ann New York Acad Sci 59:107–132
Kline N (1958) Clinical experience with iproniazid. J Clin Exp Psychopathol 19:(suppl)72–78
Kuhn R (1957) Über die Behandlung depressiver Zustände mit einem Iminodibenzylderivat (G 22355). Schw Med Wschr 87:1135–1140
Laborit H, Huguenard P, Alluaume R (1952) Un nouveau stabilisateur neuro-vegetatif, le 4560 RP. Presse Med 60:206–208
Mohler H, Okada I (1977) Benzodiazepine receptor demonstration in the central nervous system. Science 198:849–851
Muller JM, Schlitter E, Bein HJ (1952) Reserpin, der sedative Wirkstoff aus Rauwolfia serpentina Benth. Experientia 8:388–391
Olsen RW (1982) Drug interaction at the GABA receptor-ionophore complex. Ann Rev Pharmacol Toxicol 22:245–277
Petersen PV, Lassen N, Holm T, Kopf R, Nielsen M (1958) Chemical constitution and pharmacological action of some thioxanthene analogues of chlorpromazine and mepazine. Arzneim Forsch 8:395–397
Randall LO, Schallek W, Heise GA, Keith EF, Bagdorn RE (1960) The psychosedative properties of methaminodiazepoxide. J Pharmacol Exp Ther 129:163–171
Schou M (1959) Lithium in psychiatric therapy. Stock-taking after 10 years. Psychopharmacology 1:65–78
Schou M (1983) Lithium perspectives. Neuropsychobiology 10:7–12
Selikoff JJ, Robitzak E-H, Orustain GG (1952) Treatment of pulmonary tuberculosis with hydrazine derivatives of isonicotinic acid. JAMA 150:973–982
Sen S, Bose KC (1931) Rauwolfia serpentina, a new Indian drug for insanity and high blood pressure. Indian Med World 2:194–198
Squires RJ, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266:732–734
Swazey JP (1974) Chlorpromazine in psychiatry. MIT Press, Cambridge, Mass
Van Rossum J (1966) The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn 160:492–494
Winter CA (1948) The potentiating effect of antihistaminic drugs upon the sedative action of barbiturates. J Pharmacol Exp Ther 94:7–11
Zeller EA, Barsky J, Fouts JH, Kirschheimer WF, Orden JS van (1952) Influence of isonicotinic acid hydrazine and 1-isonicotinyl-2-isopropyl hydrazine in bacterial and mammalian enzymes. Experientia 8:349–350
Author information
Authors and Affiliations
Additional information
Offprint requests to: Jens Schou, Professor of Pharmacology, University of Copenhagen, 20 Juliane Mariesvej, DK-2100 Copenhagen Ø, Denmark
Rights and permissions
About this article
Cite this article
Jacobsen, E. The early history of psychotherapeutic drugs. Psychopharmacologia 89, 138–144 (1986). https://doi.org/10.1007/BF00310617
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00310617